What we do
Our mission is to undertake life science research for development of drugs and therapies for diseases. We are taking our first step towards this by developing treatment for colorectal cancer
Who we are
An ambitious research centre aiming to develop drugs and therapy for diseases starting with colorectal cancer.
Our Founder and CEO: Dr. Bene Ekine-Afolabi
She is a graduate of River State University of Science & Technology in Applied Biology (Medical Microbiology), with an MRes degree at University of East London, United Kingdom. She studied towards her PhD and worked at the Department of Natural Sciences as visiting lecturer in Haematology cancer, Middlesex University, UK.
Trained in Practical Approach to Toxicology in Drug Development (American College of Toxicology/British Toxicology Society). She received a part-sponsored training award in Cancer Biology & Therapeutics at Harvard Medical school, graduated with a Distinction (among the top six in class). Bene does research in Microbiology, Molecular Biology and Cancer Research; her current research focuses on the Investigation of molecular mechanism of colorectal cancer development, EMT, and cell death. Bene’s current project involves lead compound optimization in the development of novel therapeutic for colorectal cancer.